Voloridge Investment Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-48,911
Closed -$977K 1810
2021
Q4
$977K Buy
+48,911
New +$921K 0.01% 1271
2021
Q3
Sell
-19,736
Closed -$533K 1964
2021
Q2
$533K Buy
+19,736
New +$552K ﹤0.01% 1424
2021
Q1
Sell
-27,510
Closed -$791K 1735
2020
Q4
$791K Sell
27,510
-240,160
-90% -$6.48M 0.01% 1032
2020
Q3
$6.53M Buy
267,670
+165,733
+163% +$3.57M 0.05% 370
2020
Q2
$1.82M Buy
101,937
+26,863
+36% +$353K 0.02% 655
2020
Q1
$611K Buy
75,074
+18,174
+32% +$208K 0.02% 649
2019
Q4
$751K Sell
56,900
-120,702
-68% -$1.46M 0.01% 726
2019
Q3
$2.11M Buy
+177,602
New +$3.29M 0.04% 438

Other funds holding CVET

Voloridge Investment Management's CVET Position: Q1 2022 in Review

Voloridge Investment Management sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2022, closing a stake of 48,911 shares — an estimated $977K sold.

Voloridge Investment Management first reported a position in CVET in Q3 2019 and held it in 8 quarters. The position peaked at $6.53M in Q3 2020. 257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

  • Voloridge Investment Management reported no remaining Covetrus, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 48,911 Covetrus, Inc. Common Stock shares in Q1 2022, an estimated $977K.
  • Voloridge Investment Management first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Voloridge Investment Management's Covetrus, Inc. Common Stock position peaked at $6.53M in Q3 2020.
  • 257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.